You may also like
Use of Recombinant Activated Factor VII for Bleeding Following Operations Requiring Cardiopulmonary Bypass
Therapy with recombinant activated factor VII (rFVIIa) may be an effective treatment strategy for patients with refractory bleeding.
1 min read
Calculating Risk for Poor Outcomes After Transcatheter Aortic Valve Replacement
The object of this study is to outline the tools available to help understand the risk of transcatheter aortic valve replacement (TAVR) and the gaps in knowledge regarding TAVR risk estimation.
1 min read
Hospital Survival and Long Term Quality of Life after Emergency Institution of Venoarterial ECMO for Refractory Circulatory Collapse
We studied patients who underwent VA-ECMO due to primary cardiogenic shock or cardiac arrest between January 2008 and June 2011 at our institution.
1 min read